Thermo Fisher Scientific Inc.
0R0H.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$322.95B
Close$
$201.20
70.3% downside
Current Fair Value
70.3% downsideOvervalued by 70.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $322.95 Billion |
|---|---|
| Enterprise Value | $361.43 Billion |
| Dividend Yield | $1.84 (0.28%) |
| Earnings per Share | $17.78 |
| Beta | 0.85 |
| Outstanding Shares | 371,000,000 |
Return
| Return on Equity | 13.24% |
|---|---|
| Return on Assets | 6.17% |
| Return on Invested Capital | 8.40% |
Valuation & Multiples
| P/E Ratio | 35.34 |
|---|---|
| PEG | 480.2 |
| Price to Sales | 5.46 |
| Price to Book Ratio | 4.76 |
| Enterprise Value to Revenue | 7.8 |
| Enterprise Value to EBIT | 43.86 |
| Enterprise Value to Net Income | 51 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.81 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
$5.72
Average shareholder expectationRevenue Estimate
$11.71 B
Average shareholder expectationNext Earnings Call
Expected Date
October 21, 2026
EPS Estimate
$6.40
Average shareholder expectationRevenue Estimate
$11.95 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Thermo Fisher Scientific Inc.
75,000 employees
CEO: Marc Casper Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are acceleratin...